Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chongjie Cheng"'
Thrombospondin-1 Gene Deficiency Worsens the Neurological Outcomes of Traumatic Brain Injury in Mice
Autor:
Chongjie Cheng, Changhong Xing, Yinghua Jiang, Song Zhao, Xiaochuan Sun, Xiaoying Wang, Michael J. Whalen, Yong-Guang Yang, Zhengbu Liao, Zhanyang Yu, Eng H. Lo
Publikováno v:
International Journal of Medical Sciences
Background: Thrombospondin-1 (TSP-1) is an extracellular matrix protein that plays multiple physiological and pathophysiological roles in the brain. Experimental reports suggest that TSP-1 may have an adverse role in neuronal function recovery under
Autor:
Zongduo Guo, Jinwei Pang, Zhijian Huang, Zhipeng Teng, Chongjie Cheng, Jianhua Peng, Yue Wu, Yong Jiang, Li Jiang, Xiaochuan Sun, Fang Cao
Publikováno v:
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Vol 2019 (2019)
Oxidative Medicine and Cellular Longevity, Vol 2019 (2019)
Neuronal injury is the primary cause of poor outcome after subarachnoid hemorrhage (SAH). The apolipoprotein E (APOE) gene has been suggested to be involved in the prognosis of SAH patients. However, the role of APOE in neuronal injury after SAH has
Autor:
Xiaochuan Sun, Zongduo Guo, Zhijian Huang, Jianjun Zhong, Li Jiang, Chongjie Cheng, Fang Cao, Zhanyang Yu
Publikováno v:
Journal of Neurochemistry. 136:1017-1025
Traumatic brain injury (TBI) is the leading cause of mortality and morbidity in youth, but to date, effective therapies are still lacking. Previous studies revealed a marked response of apolipoprotein J (ApoJ) expression to the brain injury. The aim
Autor:
Xiao-Chuan Sun, Zhen-Ni Guo, Li Jiang, Zhijian Huang, Zhipeng Teng, Yue Wu, Chongjie Cheng, Yue He, Qin Hu, Fang Cao, Zongduo Guo
Publikováno v:
Stroke. 47:196-205
Background and Purpose— Early brain injury is proposed to be the primary cause of the poor outcome after subarachnoid hemorrhage (SAH), which is closely related to the neural apoptosis. To date, the relationship between peroxisome proliferator–ac
Publikováno v:
Frontiers in Pharmacology; 2023, p1-2, 2p